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Purpose: To evaluate the relationship between urodynamic detrusor overactivity (DO) and overactive bladder (OAB) symptoms 
in men and women.
Methods: We reviewed the records of adult males and females who attended a tertiary referral center for urodynamic evaluation 
of OAB syndrome symptoms with the presence or absence of DO. DO was calculated for symptoms alone or in combination. 
Results: The overall incidence of DO was 76.1% and 58.7% in male and female OAB patients, respectively. Of men 63% and 61% 
of women with urgency (OAB dry) had DO, while 93% of men and 69.8% of women with urgency and urgency urinary incon-
tinence (OAB wet) had DO. Of women, 58% who were OAB wet had stress urinary incontinence symptoms with 26.4% having 
urodynamic stress incontinence. 6% of men and 6.5% of women with OAB symptoms had urodynamic diagnosis of voiding dif-
ficulties with postvoid residual greater than 100 mL. Combination of symptoms is more accurate in predicting DO in OAB pa-
tients. The multivariate disease model for males included urge urinary incontinence (UUI) and urgency while for females it in-
cluded UUI and nocturia. 
Conclusions: There was a better correlation in results between OAB symptoms and the urodynamic diagnosis of DO in men 
than in women, more so in OAB wet than in OAB dry. Combination of symptoms of the OAB syndrome seems to have a better 
correlation with objective parameters from the bladder diary, filling cystometry, and with the occurrence of DO. 
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INTRODUCTION
According to the latest International Continence Society (ICS) 
recommendation, the overactive bladder (OAB) syndrome is 
described as the presence of urgency, with or without urge uri-
nary incontinence (UUI), usually with frequency and nocturia 
if there is no proven infection or other obvious pathological 
condition [1]. The implication of this definition is that the term 
OAB denotes a syndrome whose etiology is unknown. Gener-
ally speaking, detrusor overactivity (DO) is supposed to be a 
major underlying pathophysiology of OAB. OAB is a symptom-
atic diagnosis, while DO is an urodynamic observation defined 
by involuntary detrusor contractions during the filling phase, 
which may be spontaneous or provoked [1]. 
  Although there is consensus about the presence of these 
symptoms it is unclear how they are related, both individually 
as well as in combination, with objective parameters. Although 
improvement of symptoms is the principal goal of treatment, 
concurrent improvement in objective parameters will support 
the effectiveness of the intervention used. Some authors have 
suggested recently that patients with this symptom complex can 
be safely treated on the basis of their history, without the need 
for invasive urodynamics (UDS) tests. But whether it is an ac-
curate method of diagnosis is not known. Several studies have 
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demonstrated that urinary symptoms do not accurately diag-
nose the underlying pathology compared with UDS [2,3]. The 
bladder has been described as an unreliable witness [4]. 
  Most of the previous studies included either male or female 
patients but not both male and female patients. According to 
the new definition OAB symptoms are suggestive of DO, al-
though the definition does not specify the actual correlation 
between OAB and DO. We defined how well OAB symptoms, 
both individually as well as in combination, predict urodynam-
ic DO using the new definitions of OAB and OAB symptoms 
in men and women from the same population group.
MATERIALS AND METHODS
This was a retrospective study of men and women (aged ≥18 
years) with symptoms of an overactive bladder (urinary fre-
quency, urgency, nocturia, and/or UUI) referred to our urody-
namic unit for further evaluation, between February 2002 and 
February 2007. All UDS were done at a specialist referral center 
performing about 10 to 15 UDS tests weekly in male and female 
children and adults who undergo standard UDS. We reviewed 
urodynamic report sheets and evaluated patients’ age, voiding 
frequency (≥eight voids per day), nocturia (≥ two voids per 
night), urgency and symptomatic incontinence (OAB dry or 
OAB wet, respectively), first sensation, maximum cystometric 
capacity (MCC), bladder compliance, and the presence or ab-
sence of DO. Those with neurological, vesical, bladder outlet 
and pelvic floor diseases or surgery were excluded.
  Patients with frequency alone or nocturia alone were not 
considered to have OAB. Patient traces were examined to see if 
DO was present. Detrusor overactivity was defined as the oc-
currence of an involuntary detrusor contraction during filling 
phase, either spontaneous or provoked [1].  
  Those on antimuscarinics are instructed to stop ingesting 
them 1 week prior to attending for the test, thus, providing a 
washout period and avoiding any interference with test results.
All UDS information, including patient demographics, medical 
history, examination, voiding diary, urinalysis, urine free flow 
rate, post-void residual volume, results of the filling and voiding 
phases, and bladder capacity, are entered during the test. All 
UDS investigations were done according to the ICS good uro-
dynamics practices protocol [5]. Conventional filling cystome-
try was performed with patients in the supine position. The 
bladder was filled at a constant rate of 25 mL per minute using 
normal saline solution at room temperature for standard UDS. 
After patients denoted MCC, a series of provocative maneuvers 
were undertaken by coughing 10 times with maximal effort in 
supine and sitting positions.
  The results were statistically evaluated using Mann-Whitney 
and Fisher’s exact probability tests for comparison of the find-
ings between DO and no DO patients, and for comparison be-
tween symptoms and UDS findings. Fisher’s exact probability 
test was performed to assess the association between symptoms 
and DO. A binary logistic regression modeling selection pro-
cess was done with DO as the dependent variable and the po-
tential risk factors including symptoms as possible predictor 
variables. P-values less than 0.05 were considered statistically 
significant. All data were analyzed using the Statistical Package 
for the Social Sciences program (SPSS ver. 16.0, SPSS Inc., Chi-
cago, IL, USA).
RESULTS
Our study enrolled 209 non-neurogenic patients adult patients 
(117 men and 92 women) referred to our unit because they had 
complete persistent storage symptoms data entries available in 
the database of frequency, nocturia, urgency and/or UUI. They 
were evaluated by a urologic specialist prior to urodynamics. 
The overall incidence of DO was 76.1% (89 patients) and 58.7% 
(54 patients) in male and female OAB patients, respectively. Ten 
male DO patients and nine female DO patients revealed DO 
after provocative maneuvers, such as posture change or cough-
ing. Compared with no DO patients, DO patients revealed sig-
nificantly lower urodynamic parameters in both sexes (Table 1).
  In male, 40 of 89 (44.9%) of male DO patients were OAB wet 
and 3 of 28 no DO (10.7%) were also OAB wet. In female pa-
tients, 37 of 54 DO patients (68.5%) were OAB wet, whereas 16 
of 38 no DO patients (42.1%) were also OAB wet. Also, 63% of 
men and 61.3% of women with urgency (OAB dry) had DO, 
while 93% of men and 69.8% of women with urgency and UUI 
(OAB wet) had DO. However, 58% of women who were OAB 
wet had stress urinary incontinence (SUI) symptoms with 
26.4% having urodynamic stress incontinence.
  The associations between the reported symptoms and UDS 
findings are presented in Table 2. In men, the urgency and in-
continence symptoms were significantly associated with the 
presence of DO with lower micturition and bladder sensation 
volumes. In women, only incontinence was significantly associ-
ated with DO with a significant effect on all urodynamic pa-
rameters examined. However, there is a significant effect of 50    www.einj.org
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nocturia on badder compliance while the other parameters did 
not change significantly. We further analyzed these retrospec-
tive data to find out if clinicians could better predict DO when 
some clinical factors were present. As shown in Table 3, analysis 
of OAB symptoms and DO were studied in male and female 
subjects, separately. Of the four symptoms only incontinence 
was associated significantly with DO in male patients. In female 
patients, nocturia and incontinence were significantly associat-
ed with DO. Univariate logistic regression showed that the high-
est odds ratios (OR) of DO were for UUI in men (4.2) and 
women (2.8) (Table 4). In both sexes, age was not significantly 
involved in the risk of DO. When symptoms were studied sepa-
rately, the frequency and urgency were not significantly involved 
in risk of DO in both sexes. However, analysis of interactions 
showed that they played a role in slightly increasing the risk of 
other factors. The interaction of frequency and urgency was 
Table 1. Comparison between DO patients and no DO patients in both sexes
  Age (yr) MCC (mL) FS (mL) COMP (mL/cm H2O) OAB wet
Men    
DO (n=89) 50.8±17.6 271±61.5 117.4±19.3 24.7±4.0 40 (44.9)
No DO (n=28) 53.7±14.0 337.1±50.8 141.8±21.4 32.1±6.2 3 (10.7)
P-value 0.4 <0.001  <0.001 <0.001 0.001
Women        
DO (n=54) 46.4±14.8 280.0±27.4 105.4±11.7 51.2±4.1 37 (68.5)
No DO (n=38) 45.6±12.8 347.9±29.0 132.4±12.2 60.0±4.0 16 (42.1)
P-value 0.8 <0.001  <0.001  <0.001  0.01
Values are presented as mean±SD or number (%). 
DO, patients with detrusor overactivity; no DO, patients without detrusor overactivity; MCC, maximum cystometric capacity; FS, first sensation; 
COMP, bladder compliance; OAB, overactive bladder.
Table 2. Association of overactive bladder symptoms and urodynamics findings in men and women
 
 
Men Women
MCC (mL) FS (mL) COMP (mL/cm H2O) MCC (mL) FS (mL) COMP (mL/cm H2O)
Frequency
Yes 284.8 121.7 26.7 306.8 115.1 54.8
No 293.3 127.7 25.7 309.5 118.2 54.9
P-value 0.6 0.4 0.4 0.9 0.5 0.9
Nocturia
Yes 281.6 122.2 26.0 304.3 114.6 53.7
No 301.3 125.9 27.6 314.4 119.9 56.9
P-value 0.2 0.4 0.1 0.3 0.2 0.03
 a)
Urgency
Yes 272.0 120.3 25.4 305.3 115.2 54.3
No 316.9 129.2 28.6 320.0 122.4 57.2
P-value <0.001
 b) 0.02
 a) 0.02
 a) 0.2 0.1 0.06
UUI
Yes 265.0 116.8 23.9 296.9 112.6 53.3
No 217.5 132.2 29.9 334.8 125.9 58.6
P-value <0.001
 b) <0.001
 b) <0.001
 b) <0.001
 b) 0.001
 b) <0.001
 b)
UUI, urge urinary incontinence; MCC, maximum cystometric capacity; FS, first sensation; COMP, bladder compliance.
a)P<0.05. 
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significant in men (P=0.04) but not in women (P=0.1).
  As for binary interactions in men, the most noticeable was 
the urgency and incontinence (P=0.003). The OR of inconti-
nence increased from 4.2 to 6.8 by the addition of the urgency 
(thus neglecting the cases with urgency alone). Further, the re-
sults show nearly a doubling in OR when any of the other fac-
tors is added to these two. Adding either nocturia or frequency 
increased the OR to 12.4 (P=0.02).
  In women, the situation is different. Since univariate risks of 
nocturia and incontinence were significant, further interactions 
showed more significant risks, namely the interactions of noctu-
ria with either frequency (P=0.005) or incontinence (P=0.008). 
Although incontinence had the highest OR in univariate analy-
sis, the interactions showed that frequency and nocturia were 
the major risk players in women. Adding either incontinence or 
urgency to these two factors increased the OR to 11.5 (P=0.002). 
  Multivariate logistic regression was used for prediction of the 
direct risk factors involved in the disease model. The OR in a 
multivariate model represents the exponential factor for each 
variable in a one equation (Table 5). The disease model for males 
included UUI and urgency while for females it included UUI 
and nocturia. So far, the results of multivariate analysis were 
Table 3. Association of detrusor overactivity and selected factors
Men Women
DO P-value DO P-value
Age 0.5
≥50 42 (47.2) 0.2 21 (38.9)
<50 17 (60.7) 16 (42.1)
Frequency 0.3
Yes 67 (75.3) 0.4 31 (57.4)
No 20 (71.4) 19 (50.0)
Nocturia 0.03
 a)
Yes 67 (75.3) 0.2 39 (72.2)
No 18 (64.3) 19 (50.0)
Urgency 0.2
Yes 63 (70.8) 0.07 46 (85.2)
No 15 (53.6) 29 (76.3)
UUI 0.02
 a)
Yes 59 (66.3) 0.001
 b) 43 (79.6)
No 9 (32.1) 22 (57.9)
Values are presented as number (%). 
UUI, urge urinary incontinence; DO, detrusor overactivity.
a)P<0.05. 
b)P<0.001.
Table 4. Univariate binary logistic regression analysis for odds ratios of detrusor overactivity
Factors
Men Women
OR 95% CI P-value OR 95% CI P-value
Univariate Age (≥50) 0.5 0.2-1.4 0.2 0.9 0.4-2.0 0.8
Frequency  1.2 0.5-3.2 0.7 1.3 0.6-3.1 0.5
Nocturia 1.7 0.7-4.2 0.3 2.6 1.1-6.2 0.03
 a)
Urgency 2.1 0.9-5.0 0.1 1.8 0.6-5.1 0.3
UUI 4.2 1.7-10.3 0.002
 a) 2.8 1.1-7.2 0.03
 a)
Interactions Fr×Nocturia 1.4 0.6-3.2 0.5 4.1 1.5-10.9 0.005
 a)
Fr×Urgency 2.6 1.1-6.3 0.04
 a) 2.0 0.8-4.8 0.1
Fr×UUI 3.0 1.1-8.1 0.03
 a) 3.3 1.2-8.8 0.02
 a)
Nocturia×Urgency 3.2 1.2-8.3 0.02
 a) 3.2 1.3-7.5 0.01
 a)
Nocturia×UUI 3.3 1.2-8.9 0.02
 a) 3.3 1.4-8.0 0.008
 a)
Urgency×UUI 6.8 1.9-24.2 0.003
 a) 3.0 1.3-7.1 0.01
 a)
Fr×Nocturia×UUI 1.9 0.7-5.5 0.2 11.5 2.5-52.7 0.002
 a)
Fr×Nocturia×Urgency 3.7 1.2-11.6 0.02
 a) 11.5 2.5-52.7 0.002
 a)
Nocturia x UUI×Urgency 12.4 1.6-95.8 0.02
 a) 4.1 1.5-10.9 0.005
 a)
Fr×Urgency×UUI 12.4 1.6-95.8 0.02
 a) 6.9 1.9-25.2 0.004
 a)
UUI, urge urinary incontinence; Fr, frequency; OR, odds ratio; CI, confidential interval.
a)P<0.05.52    www.einj.org
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consistent with the binary interactions. However, in the case of 
women, the frequency was neglected from the model for simple 
reason of insignificant univariate result, which is a rule for mul-
tivariate model prediction. 
DISCUSSION
In the latest recommendation, the ICS had updated the defini-
tion for OAB syndrome into urgency, with or without urge in-
continence, usually with frequency and nocturia [1]. The main 
symptom of this definition is the urgency symptom, but it is 
unclear what this is based on. Although according to the ICS 
definition, urodynamic study is not required routinely to make 
a diagnosis of OAB, some physicians are concerned that a cor-
rect diagnosis will be missed in many patients, and they will not 
receive appropriate treatment because the bladder has been de-
scribed as an unreliable witness [6].
  Sekido et al. [7] retrospectively evaluated 50 patients (12 
males and 38 females) with OAB symptoms in regard to urody-
namic parameters and the presence or absence of DO. The over-
all incidence of DO was 75% and 36.8% in male and female pa-
tients, respectively. They concluded that, in contrast to male 
OAB, DO might not be a major underlying cause of uncompli-
cated female OAB. Therefore, the prevalence of DO in OAB fe-
males may depend on the population studied, the definition of 
this condition and the methods used. 
  Each symptom of frequency, nocturia, urgency and inconti-
nence was associated with lower micturition and sensation vol-
umes on filling cystometry. This association was not significant 
except for each of urgency and incontinence in men and incon-
tinence alone in women. Of the four symptoms that are current-
ly considered to be part of the OAB syndrome, the incontinence 
symptom is the best associated with objective parameters from 
the bladder diary, filling cystometry, and with the occurrence of 
DO in both sexes. Although urgency is associated with a signif-
icant effect on all urodynamic parameters examined in men, 
there is no significant effect on the occurrence of DO (Tables 2, 
3). We agree with the others that there is a need for a validated 
urgency scale that measures urgency rather than bladder sensa-
tion [8,9]. In univariate analysis, when symptoms studied sepa-
rately, the frequency and urgency were not significantly involved 
in risk of DO in both sexes while interactions showed that both 
slightly increase the risk of other factors. The interaction of these 
was significant in men but not in women (Table 4). This is sup-
portive to our belief that OAB symptoms may have different 
pathophysiology in both sexes. We believe clinicians could bet-
ter predict DO when some clinical factors were combined to-
gether and not by depending on a single symptom. This is obvi-
ous from the binary interactions of OAB symptoms such as ur-
gency and incontinence. Incontinence is usually associated with 
urgency, so this can explain the increase in OR of incontinence 
from 4.2 to 6.8 by the addition of the urgency in men. Further-
more, the results show nearly a doubling in OR when any of the 
other symptoms is added to these two symptoms.
  In women univariate risks of nocturia and incontinence were 
significant and further interactions showed more significant 
risks, namely the interactions of nocturia with either frequency 
or incontinence. Although incontinence had the highest OR in 
univariate analysis, the interactions showed that frequency and 
nocturia were the major risk factors in women in contrast to 
men. The frequency is univariately weakly predictive of DO but 
not significant in a multivariate model with urgency, inconti-
nence and nocturia. This is similar to the findings of other au-
thors demonstrated by a self reported mail questionnaire in 
women [10]. Also, Hashim and Abrams [8] showed in their 
study that increasing voiding frequency did not have any effect 
on increasing the accuracy of diagnosis of DO except in women 
with 10 or more daytime micturition episodes. However, we 
cannot ignore the role of frequency in predicting DO especially 
when combined with other symptoms. Van Brummen et al. 
[11] investigated the association between overactive bladder 
symptoms in women and objective parameters from the blad-
der diary and conventional filling cystometry. The frequency 
symptom as well as the UUI symptom was significantly associ-
ated with the presence of DO. They considered the frequency 
symptom as being obligatory for considering one to have an 
OAB. The weakness in their study and our study is that analysis 
Table 5. Multivariate binary logistic regression analysis for odds 
ratios of detrusor overactivity in both sexes
Factors OR 95% CI P-value
Men
Urgency 2.7 1.0-7.0 0.04
 a)
UUI 4.8 1.9-12.5 0.001
 a)
Women
Nocturia 2.6 1.1-6.4 0.04
 a)
UUI 2.9 1.1-7.4 0.03
 a)
UUI, urge urinary incontinence; Fr, frequency; OR, odds ratio; CI, 
confidential interval.
a)P<0.05.www.einj.org    53
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was not done to assess whether increasing frequency made a 
difference to the diagnostic value and association between OAB 
and DO, using different cutoff points for frequency.
  Urgency in men was associated with DO in multivariate 
analysis, but not in univariate analysis. Some authors stated the 
frequency symptom, not the urgency symptom, is best associ-
ated with them in females who underwent UDS [11]. Con-
versely, frequency alone was reported to be a poor predictor of 
DO (31.4%) in female OAB patients, and having urgency, fre-
quency and UUI had the highest sensitivity in predicting DO 
(61.0%) in females. In our study, 62% of women with frequency 
alone have DO, while 87% with combined urgency, frequency 
and UUI have DO. This confirms the need for a validated ur-
gency scale that measures urgency more accurately. 
  This study adds to the body of evidence that questions the 
validity of using invasive urodynamic procedures before initiat-
ing treatment for the debilitating symptoms of an OAB. Indeed, 
the results of a randomized, double-blind clinical trial in which 
patients were enrolled and treated on the basis of symptoms 
alone support this management strategy [12]. This approach 
would encourage more physicians to explore these problems 
with their patients, reserving referral for costly urodynamics for 
those patients who fail to respond to first-line therapy. This 
management strategy may be suitable for our people with limit-
ed income to pay for the tests. For this reason, UDS should be 
done only if it is going to change patient treatment or help dif-
ferentiate the etiology of voiding dysfunction, or if it is done af-
ter failed conservative/medical treatment [13]. If standard UDS 
fails to reproduce symptoms, referral for ambulatory UDS may 
be considered when available. The absence of DO during an ar-
tificial bladder test even with provocative maneuvers is not an 
absolute confirmation of lack of DO in “real life” situations. 
  The present study had several limitations. First, the study was 
retrospective. Second, our study population was a selected group 
of patients with complaints that were candidate for urodynamic 
investigation. Therefore, they represent patients with bother-
some symptoms. To what extent our results can be generalized 
to the population remains unanswered. Third, the study com-
pares subjective symptoms with objective parameters. The 
bladder is a bad witness, and the symptoms of frequency, noc-
turia, and urgency may arise because of hypersensitivity of the 
bladder stretch but also may occur when the bladder contracts 
inappropriately due to DO. Fourth, the follow-up data were 
lacking in some patients because some in the present study 
were referred to our urology unit purely for management for a 
short duration. Therefore, there was not adequate information 
regarding whether or not urodynamic findings altered manage-
ment for these patients. Continuing arguments against ‘no need 
for UDS in OAB patients’ might prove fruitless. Rather, we need 
knowledge and/or evidence-based guidelines that define the 
OAB patients in whom UDS could confer a benefit.
  In conclusion, the definition of OAB based on urgency is a 
better predictor in men than in women. When symptoms were 
used together, only urgency and UUI in men and nocturia and 
UUI in women significantly increased the prediction of DO. It 
is important to inquire about the reproduction of symptoms 
during UDS and correlate this with findings during the test. 
There is a need for a validated urgency scale that measures ur-
gency rather than bladder sensation. The pathophysiology of 
female OAB might be different from that of male OAB. There-
fore, treatment outcomes must be evaluated for males and fe-
males, separately. Further prospective studies are needed to 
provide more information about the precise role of urodynam-
ics for men and women with OAB symptoms. 
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